Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website https://jh.elmerpub.com

Case Report

Volume 14, Number 5, October 2025, pages 267-272

Acute Undifferentiated Leukemia Presented With Mediastinal Sarcoma

Figures

↓  Figure 1. Bone marrow aspirate (a, b, c) showing the blasts infiltrating the bone marrow, the morphology is more toward myeloid leukemia. Bone marrow biopsy (d, e) showing diffuse total infiltration by blasts.
Figure 1.
↓  Figure 2. Flow cytometry of acute undifferentiated leukemia case showing blast population (red) positive for CD45 (a), negative for lineage-specific antigen (b, c, d), negative for T-cell markers (e, f), positive for CD7 (g, h), positive for primitive markers, which are CD34, HLA-DR, and CD38, and negative for CD117 (i, j, k), positive for only one myeloid marker CD33 (l), and negative for all other markers (m, n, o, p, q, r, s, t). HLA-DR: human leukocyte antigen-DR isotype.
Figure 2.

Table

↓  Table 1. Timeline of the Case
 
Time point Event Description
SOB: shortness of breath; CXR: chest X-ray; CT: computed tomography; PET: positron emission tomography; AUL: acute undifferentiated leukemia.
Day 0 Patient presented with SOB CXR showed right pleural effusion
Day 5 Pleurocentesis Exudative fluid
Day 8 Echocardiogram Pericardial effusion
Day 15 Chest CT scan Posterior mediastinal mass
Day 18 Mediastinal mass biopsy Myeloid sarcoma
Day 19 PET scan Bulky hypermetabolic mediastinal mass with bone marrow hyperactivity
Day 28 Bone marrow aspirate AUL